Laborama, UAB - financials and debts

Company age: 14 y. 2 mo.

Update

Laborama - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,488,250 4,247,298 8,858,784 6,974,029 8,199,208 9,995,163 8,131,979 8,958,594
Profit before tax 75,353 138,896 1,667,729 369,292 591,818 399,867 30,645 156,739
Net profit 65,667 115,438 1,429,390 310,950 500,783 340,026 22,179 146,556
Equity 65,688 181,126 1,610,516 1,921,466 2,422,249 2,762,275 2,784,454 2,931,010
Liabilities 804,447 351,341 288,397 192,628 120,647 198,001 124,392 156,968
Non-current assets 6,111 4,506 2,778 7,225 16,076 - 29,829 30,593
Current assets 864,024 559,275 2,270,523 2,224,075 2,578,910 3,195,445 3,144,125 3,133,766
Total assets 870,135 563,781 2,273,301 2,231,300 2,594,986 3,195,445 3,173,954 3,164,359
Taxes paid
Social insurance contributions - - - - - 111,817 139,901 143,129
Financial indicators
Revenue change y/y - +70.7% +108.6% -21.3% +17.6% +21.9% -18.6% +10.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.5% 20.5% 62.9% 13.9% 19.3% 10.6% 0.7% 4.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% 63.7% 88.8% 16.2% 20.7% 12.3% 0.8% 5.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 2.6% 2.7% 16.1% 4.5% 6.1% 3.4% 0.3% 1.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.0% 3.3% 18.8% 5.3% 7.2% 4.0% 0.4% 1.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 12.2 1.9 0.2 0.1 0.0 0.1 0.0 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 211,766 389,064 770,329 658,965 669,323 922,633 702,043 736,321

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Laborama - Social security debts

From To Debt, €
2025-04-05 2025-04-13 817.33
2025-04-04 2025-04-04 733.09
2025-03-18 2025-04-03 817.33
2025-02-18 2025-03-13 1872.29
2025-02-11 2025-02-12 3180.29
2025-02-10 2025-02-10 3210.09
2025-02-06 2025-02-09 3180.29
2025-01-16 2025-02-05 3210.09
2025-01-02 2025-01-13 4242.42
2024-12-30 2024-12-31 4158.18
2024-12-22 2024-12-29 4242.42
2024-12-17 2024-12-20 4242.42
2024-11-18 2024-12-11 5274.81
2024-10-16 2024-11-13 7255.87
2024-09-20 2024-10-13 8302.75
2024-09-19 2024-09-19 8256.44
2024-09-17 2024-09-18 8255.54
2024-08-19 2024-09-10 9291.34
2024-07-16 2024-08-13 10329.63
2024-06-25 2024-07-11 11381.14
2024-06-21 2024-06-24 11313.64
2024-06-18 2024-06-20 11381.14
2024-06-13 2024-06-17 971.76
2024-05-16 2024-06-12 12003.76
2024-04-16 2024-05-13 13106.45
2024-03-18 2024-04-11 12991.49
2024-03-13 2024-03-17 764.33
2024-02-19 2024-03-12 14096.33
2024-02-12 2024-02-18 4381.30
2024-01-16 2024-02-11 15213.30
2024-01-15 2024-01-15 6962.95
2023-12-18 2024-01-11 16294.95
2023-12-14 2023-12-17 6938.65
2023-11-16 2023-12-13 17470.65
2023-11-14 2023-11-15 8077.23
2023-10-17 2023-11-13 18509.23
2023-10-12 2023-10-16 9646.51
2023-09-18 2023-10-11 19558.51
2023-09-13 2023-09-17 10532.43
2023-08-17 2023-09-12 20594.43
2023-08-14 2023-08-16 10983.42
2023-07-18 2023-08-13 21635.42
2023-07-13 2023-07-17 13225.68
2023-06-16 2023-07-12 22707.68
2023-06-13 2023-06-15 14368.87
2023-05-16 2023-06-12 23750.87
2023-05-11 2023-05-15 13765.16
2023-05-02 2023-05-10 24797.16
2023-04-18 2023-04-28 24797.16
2023-04-13 2023-04-17 15100.03
2023-03-16 2023-04-12 25832.03
2023-03-14 2023-03-15 15044.11
2023-02-17 2023-03-13 26876.11
2023-02-14 2023-02-16 16846.72
2023-02-06 2023-02-13 27928.72
2023-01-17 2023-02-03 27928.72
2023-01-13 2023-01-16 19952.76
2022-12-16 2023-01-12 28984.76
2022-12-14 2022-12-15 20650.19
2022-11-21 2022-12-13 30282.19
2022-11-17 2022-11-18 30282.19
2022-11-15 2022-11-16 21813.77
2022-10-18 2022-11-14 31345.77
2022-10-13 2022-10-17 23256.50
2022-09-23 2022-10-12 32388.50
2022-09-16 2022-09-22 32324.32
2022-09-14 2022-09-15 24029.11
2022-08-23 2022-09-13 33361.11
2022-08-12 2022-08-22 19849.28
2022-07-18 2022-08-11 35381.28
2022-07-14 2022-07-17 26617.34
2022-06-16 2022-07-13 36449.34
2022-06-14 2022-06-15 26998.74
2022-05-17 2022-06-13 37330.74
2022-05-12 2022-05-16 26906.54
2022-04-19 2022-05-11 38262.28
2022-04-14 2022-04-18 18697.97
2022-03-16 2022-04-13 39429.97
2022-03-14 2022-03-15 31244.30
2022-02-17 2022-03-13 40461.97
2022-02-14 2022-02-16 32804.73
2022-01-26 2022-02-13 41466.73
2022-01-18 2022-01-25 41466.75
2022-01-14 2022-01-17 34868.00
2021-12-17 2022-01-13 42600.00
2021-12-16 2021-12-16 42600.01
2021-12-13 2021-12-15 35931.86
2021-11-16 2021-12-12 43632.86
2021-11-15 2021-11-15 35802.84
2021-10-18 2021-11-14 44672.76
2021-10-14 2021-10-17 38495.38
2021-09-16 2021-10-13 45727.38

Laborama - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Laborama, UAB (code 302818839) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €8.96M, up 10.2% year on year, after €8.13M in 2024. Compared with 2023 revenue of €10.00M, the latest result still remains below the earlier peak, indicating a partial recovery rather than a full return to prior levels. Net profit increased to €146.6K in 2025 from €22.2K in 2024, while 2023 net profit was €340.0K. Profitability improved, with a 1.6% margin in 2025 versus 0.3% in 2024, although it remained below the 3.4% level recorded in 2023. The balance sheet stayed conservative: total assets were €3.16M, equity €2.93M, and liabilities €157.0K. This implies a strong equity position and low leverage, supported by a debt-to-equity ratio of 0.05 and an equity ratio of 92.6%. Efficiency remained solid, with asset turnover of 2.83x. Revenue per employee was €746.5K, and profit per employee was €12.2K in 2025.